Immunology: Current Research
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Review Article   
  • Immunol Curr Res, Vol 7(6): 174
  • DOI: 10.4172/icr.1000174

Targeting T Cells in Cancer Immunotherapy

Alexey Chiron*
Cellular and Molecular Research Center, Cellular and Molecular Medicine Institute, Urmia University of Medical Sciences, Urmia, Iran
*Corresponding Author : Alexey Chiron, Cellular and Molecular Research Center, Cellular and Molecular Medicine Institute, Urmia University of Medical Sciences, Urmia, Iran, Email: alexey663@gmail.com

Received Date: Nov 02, 2023 / Published Date: Nov 30, 2023

Abstract

Cancer immunotherapy has emerged as a revolutionary approach in the battle against cancer, focusing on harnessing the body's immune system to target and destroy malignant cells. T cells, a critical component of the immune system, play a central role in this therapeutic strategy. This abstract provides a concise overview of the stateof- the-art in Targeting T Cells in Cancer Immunotherapy.

Citation: Chiron A (2023) Targeting T Cells in Cancer Immunotherapy. ImmunolCurr Res, 7: 174. Doi: 10.4172/icr.1000174

Copyright: © 2023 Chiron A. This is an open-access article distributed under theterms of the Creative Commons Attribution License, which permits unrestricteduse, distribution, and reproduction in any medium, provided the original author andsource are credited.

Top